Morepen Laboratories’ arm gets nod to form new subsidiary company

19 Feb 2025 Evaluate

Morepen Laboratories’ wholly owned subsidiary-- Dr. Morepen (DML) has received approval from Board of Directors for the formation of a new subsidiary company on February 19, 2025. The proposed entity will be named ‘Quick Med’ or any other name as approved by the Central Registration Centre, Ministry of Corporate Affairs (Proposed Company). 

Upon incorporation, the proposed company will become a step-down subsidiary of Morepen Laboratories. The proposed new company will operate in the pharmaceutical sector, specializing in the 'Online Retail Pharmacy' business.  

Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products. 


Morepen Laboratories Share Price

48.54 1.07 (2.25%)
27-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1731.20
Dr. Reddys Lab 1162.35
Cipla 1483.00
Lupin 2019.20
Zydus Lifesciences 891.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...